Summit Therapeutics Inc.

AI Score

XX

Unlock

24.61
1.56 (6.77%)
At close: Apr 17, 2025, 3:59 PM
24.79
0.75%
After-hours: Apr 17, 2025, 07:56 PM EDT

Summit Therapeutics Revenue Breakdown

Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
License and Service Revenue 220K 235K 250K 251K 1.31M 57K 192K 185K 181K
License and Service Revenue Growth -6.38% -6.00% -0.40% -80.83% +2196.49% -70.31% +3.78% +2.21% n/a

Revenue by Geography

Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Latin America Revenue 705K 1.81M 860K 457K
Latin America Revenue Growth -61.03% +110.35% +88.18% n/a

Operating Expense Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Oct 31, 2019 Jul 31, 2019 Apr 30, 2019 Jan 31, 2019 Oct 31, 2018 Jul 31, 2018 Apr 30, 2018 Jan 31, 2018 Oct 31, 2017 Jul 31, 2017 Apr 30, 2017 Jan 31, 2017 Oct 31, 2016 Jul 31, 2016 Apr 30, 2016 Jan 31, 2016 Oct 31, 2015 Jul 31, 2015 Apr 30, 2015 Jan 31, 2015
Selling, General, and Administrative Revenue 20.39M 13.95M 11.73M 11.61M 5.43M 6.32M 6.94M 7.54M 5.57M 6.93M 6.66M 7.78M 5.66M 5.98M 4.18M 3.84M 7.46M 5.3M 798.54K 2.58M 5.63M 1.46M 2.14M 3.96M 5.92M 3.56M 3.67M 7.21M 2.62M 3.27M 3.15M 3.78M 2.33M 2.52M 2.09M 1.98M 2.01M 1.56M 1.66M 1.97M
Selling, General, and Administrative Revenue Growth +46.15% +18.94% +1.02% +113.65% -13.96% -8.99% -7.90% +35.21% -19.62% +4.11% -14.41% +37.41% -5.38% +42.99% +8.98% -48.53% +40.78% +563.59% -69.05% -54.21% +284.78% -31.59% -46.01% -33.04% +66.48% -3.25% -49.05% +175.61% -19.97% +3.90% -16.82% +62.57% -7.78% +20.60% +5.48% -1.17% +28.40% -5.72% -15.86% n/a
Research and Development Revenue 37.72M 30.8M 30.87M 24.81M 15.32M 9.45M 9.88M 5.39M 17.05M 9.01M 20.56M 23.11M 16.13M 19.72M 14.7M 12.26M 14.39M 11.48M 14.89M 6.38M 9.32M 10.6M 10.7M 12.51M 10.42M 12.44M 15.5M 14.02M 9.81M 8.69M 6.51M 5.99M 4.83M 7.13M 7.02M 7.12M 6.95M 6.59M 4.83M 4.18M
Research and Development Revenue Growth +22.49% -0.24% +24.42% +61.94% +62.13% -4.37% +83.49% -68.41% +89.27% -56.18% -11.04% +43.27% -18.21% +34.14% +19.86% -14.76% +25.31% -22.88% +133.50% -31.59% -12.10% -0.89% -14.50% +20.13% -16.26% -19.74% +10.56% +42.88% +12.95% +33.40% +8.69% +24.03% -32.29% +1.55% -1.31% +2.46% +5.40% +36.38% +15.58% n/a